Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001129928-22-000017
Filing Date
2022-03-03
Accepted
2022-03-03 16:55:08
Documents
126
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 20-F oncyf-20211231.htm   iXBRL 20-F 2218394
2 EX-1.1 articles.htm EX-1.1 19538
3 EX-1.2 ex12onc-2017byxlaws1636459.htm EX-1.2 44800
4 EX-2.1 ex21exdescriptionofsecurit.htm EX-2.1 3136
5 EX-4.18 ex418mattcoffeyamendment3-.htm EX-4.18 14375
6 EX-4.19 ex419kirklookamendment3-em.htm EX-4.19 14450
7 EX-4.20 ex420allisonhagermanamendm.htm EX-4.20 14991
8 EX-4.21 ex421andrewdeguttadauroame.htm EX-4.21 14794
9 EX-4.22 ex422thomasheinemanamendme.htm EX-4.22 22091
10 EX-8.0 ex80subsidiaries2021.htm EX-8.0 3624
11 EX-12.1 ex121ceocertification2021.htm EX-12.1 9912
12 EX-12.2 ex122cfocertification2021.htm EX-12.2 9682
13 EX-13.1 ex131ceocertification2021.htm EX-13.1 5139
14 EX-13.2 ex132cfocertification2021.htm EX-13.2 4776
15 EX-15.1 ex151-2021mda.htm EX-15.1 399076
16 EX-15.2 ex152ey2021consent.htm EX-15.2 6414
17 articles001.jpg GRAPHIC 193024
18 articles002.jpg GRAPHIC 131925
19 articles003.jpg GRAPHIC 164242
20 articles004.jpg GRAPHIC 189812
21 articles005.jpg GRAPHIC 238635
22 articles006.jpg GRAPHIC 163182
23 articles007.jpg GRAPHIC 278217
24 articles008.jpg GRAPHIC 198799
25 articles009.jpg GRAPHIC 159530
26 articles010.jpg GRAPHIC 159006
27 articles011.jpg GRAPHIC 106912
28 articles012.jpg GRAPHIC 225065
29 oncolyticslogotaglinebluea.jpg GRAPHIC 367326
30 oncyf-20211231_g1.jpg GRAPHIC 148102
31 oncyf-20211231_g2.jpg GRAPHIC 460603
32 oncyf-20211231_g3.jpg GRAPHIC 6561
33 eyheadera.jpg GRAPHIC 2717
  Complete submission text file 0001129928-22-000017.txt   14586853

Data Files

Seq Description Document Type Size
34 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncyf-20211231.xsd EX-101.SCH 78426
35 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oncyf-20211231_cal.xml EX-101.CAL 45427
36 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oncyf-20211231_def.xml EX-101.DEF 281203
37 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncyf-20211231_lab.xml EX-101.LAB 655121
38 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncyf-20211231_pre.xml EX-101.PRE 449588
120 EXTRACTED XBRL INSTANCE DOCUMENT oncyf-20211231_htm.xml XML 1566485
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38512 | Film No.: 22709926
SIC: 2834 Pharmaceutical Preparations